Abstract:Plant pathogens like virus, bacteria, and fungi incur a huge loss of global productivity. Targeting the dominant R gene resulted in the evolution of resistance in pathogens, which shifted plant pathologists' attention toward host susceptibility factors (or S genes). Herein, the application of sequence-specific nucleases (SSNs) for targeted genome editing are gaining more importance, which utilize the use of meganucleases (MN), zinc finger nucleases (ZFNs), transcription activator-like effector-based nucleases (TALEN) with the latest one namely clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated protein 9 (Cas9). The first generation of genome editing technologies, due to their cumbersome nature, is becoming obsolete. Owing to its simple and inexpensive nature the use of CRISPR/Cas9 system has revolutionized targeted genome editing technology. CRISPR/Cas9 system has been exploited for developing resistance against virus, bacteria, and fungi. For resistance to DNA viruses (mainly single-stranded DNA viruses), different parts of the viral genome have been targeted transiently and by the development of transgenic plants. For RNA viruses, mainly the host susceptibility factors and very recently the viral RNA genome itself have been targeted. Fungal and bacterial resistance has been achieved mainly by targeting the host susceptibility genes through the development of transgenics. In spite of these successes CRISPR/Cas9 system suffers from off-targeting. This and other problems associated with this system are being tackled by the continuous discovery/evolution of new variants. Finally, the regulatory standpoint regarding CRISPR/Cas9 will determine the fate of using this versatile tool in developing pathogen resistance in crop plants.

Type I-E CRISPR-Cas System as a Defense System in Saccharomyces cerevisiae

The Application of CRISPR-Cas9 Genome Editing in Caenorhabditis elegans

Genome engineering in Saccharomyces cerevisiae using CRISPR-Cas systems

The CRISPR/Cas system: Gene Editing by bacterial defense

Gene drive inhibition by the anti-CRISPR proteins AcrIIA2 and AcrIIA4 in Saccharomyces cerevisiae

Genome editing in mammalian cells using the CRISPR type I-D nuclease

Type II-C CRISPR-Cas9 Biology, Mechanism, and Application

Exploiting activation and inactivation mechanisms in type I-C CRISPR-Cas3 for genome-editing applications

CRISPR-Cas based genome editing for eradication of human viruses

CRISPR-Mediated Viral Gene Knockout to Investigate Viral Evasion of Antiviral Innate Immunity

Progress in Gene Editing and Metabolic Regulation of Saccharomyces cerevisiae with CRISPR/Cas9 Tools

Progress in Gene Editing and Metabolic Regulation of <i>Saccharomyces cerevisiae</i> with CRISPR/Cas9 Tools

CRISPR/Cas9: A Novel Weapon in the Arsenal to Combat Plant Diseases

Anti-CRISPR proteins targeting the CRISPR-Cas system enrich the toolkit for genetic engineering

CRISPR-Cas9: A Powerful Tool to Efficiently Engineer Saccharomyces cerevisiae

CRISPR/Cas Systems: Delivery and Application in Gene Therapy

[A Test System for Assessment of the Activity of Mutant Cas9 Variants in Saccharomyces cerevisiae].

Type III-A CRISPR systems as a versatile gene knockdown technology

The CRISPR-Cas system: its origin, functions and applications in biotechnology: A Review

Advances in CRISPR-Cas systems for human bacterial disease

An overview and potential of CRISPR-Cas systems for genome editing